These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29059199)

  • 1. Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis.
    Ahn J; Kim HJ; Choi JI; Lee KN; Shim J; Ahn HS; Kim YH
    PLoS One; 2017; 12(10):e0185680. PubMed ID: 29059199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of different beta-blockers in the treatment of long QT syndrome.
    Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
    J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.
    Goldenberg I; Bradley J; Moss A; McNitt S; Polonsky S; Robinson JL; Andrews M; Zareba W;
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):893-901. PubMed ID: 20233272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome.
    Chatrath R; Bell CM; Ackerman MJ
    Pediatr Cardiol; 2004; 25(5):459-65. PubMed ID: 15534720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3).
    Kutyifa V; Daimee UA; McNitt S; Polonsky B; Lowenstein C; Cutter K; Lopes C; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12537. PubMed ID: 29504689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-specific effect of beta-adrenergic blockade on corrected QT interval in the long QT syndrome.
    Extramiana F; Maison-Blanche P; Denjoy I; De Jode P; Messali A; Labbé JP; Leenhardt A
    Ann Noninvasive Electrocardiol; 2013 Jul; 18(4):399-408. PubMed ID: 23879280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol.
    Chockalingam P; Crotti L; Girardengo G; Johnson JN; Harris KM; van der Heijden JF; Hauer RN; Beckmann BM; Spazzolini C; Rordorf R; Rydberg A; Clur SA; Fischer M; van den Heuvel F; Kääb S; Blom NA; Ackerman MJ; Schwartz PJ; Wilde AA
    J Am Coll Cardiol; 2012 Nov; 60(20):2092-9. PubMed ID: 23083782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype.
    Zareba W; Moss AJ; Locati EH; Lehmann MH; Peterson DR; Hall WJ; Schwartz PJ; Vincent GM; Priori SG; Benhorin J; Towbin JA; Robinson JL; Andrews ML; Napolitano C; Timothy K; Zhang L; Medina A;
    J Am Coll Cardiol; 2003 Jul; 42(1):103-9. PubMed ID: 12849668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.
    Priori SG; Napolitano C; Schwartz PJ; Grillo M; Bloise R; Ronchetti E; Moncalvo C; Tulipani C; Veia A; Bottelli G; Nastoli J
    JAMA; 2004 Sep; 292(11):1341-4. PubMed ID: 15367556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cohort, genotype, variant, and maternal β-blocker treatment on foetal heart rate predictors of inherited long QT syndrome.
    Kaizer AM; Winbo A; Clur SB; Etheridge SP; Ackerman MJ; Horigome H; Herberg U; Dagradi F; Spazzolini C; Killen SAS; Wacker-Gussmann A; Wilde AAM; Sinkovskaya E; Abuhamad A; Torchio M; Ng CA; Rydberg A; Schwartz PJ; Cuneo BF
    Europace; 2023 Nov; 25(11):. PubMed ID: 37975542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome.
    Wong JA; Gula LJ; Klein GJ; Yee R; Skanes AC; Krahn AD
    Circ Arrhythm Electrophysiol; 2010 Apr; 3(2):120-5. PubMed ID: 20071715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome.
    Younis A; Bos JM; Zareba W; Aktas MK; Wilde AAM; Tabaja C; Bodurian C; Tobert KE; McNitt S; Polonsky B; Shimizu W; Ackerman MJ; Goldenberg I
    JAMA Cardiol; 2023 Aug; 8(8):775-783. PubMed ID: 37436769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.
    Moss AJ; Zareba W; Hall WJ; Schwartz PJ; Crampton RS; Benhorin J; Vincent GM; Locati EH; Priori SG; Napolitano C; Medina A; Zhang L; Robinson JL; Timothy K; Towbin JA; Andrews ML
    Circulation; 2000 Feb; 101(6):616-23. PubMed ID: 10673253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and Genotype-Dependence of intrinsic chronotropic insufficiency among patients with congenital long QT syndrome.
    Kulkarni VK; Pinsky AM; Bos JM; Neves R; Bains S; Giudicessi JR; Allison TG; Ackerman MJ
    J Cardiovasc Electrophysiol; 2024 Oct; ():. PubMed ID: 39428612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Cardiac Events Associated With Antidepressant Therapy in Patients With Long QT Syndrome.
    Wang M; Szepietowska B; Polonsky B; McNitt S; Moss AJ; Zareba W; Auerbach DS
    Am J Cardiol; 2018 Jan; 121(2):182-187. PubMed ID: 29174490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium channel blockers in the management of long QT syndrome types 3 and 2: A system review and meta-analysis.
    Yang Y; Lv TT; Li SY; Zhang P
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):3057-3067. PubMed ID: 34427958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.
    Koponen M; Havulinna AS; Marjamaa A; Tuiskula AM; Salomaa V; Laitinen-Forsblom PJ; Piippo K; Toivonen L; Kontula K; Viitasalo M; Swan H
    BMC Med Genet; 2018 Apr; 19(1):56. PubMed ID: 29622001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with bisoprolol in long-QT1 and long-QT2 syndrome.
    Steinberg C; Padfield GJ; Al-Sabeq B; Adler A; Yeung-Lai-Wah JA; Kerr CR; Deyell MW; Andrade JG; Bennett MT; Yee R; Klein GJ; Green M; Laksman ZW; Krahn AD; Chakrabarti S
    J Interv Card Electrophysiol; 2016 Nov; 47(2):163-170. PubMed ID: 27394160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.
    Schwartz PJ; Priori SG; Spazzolini C; Moss AJ; Vincent GM; Napolitano C; Denjoy I; Guicheney P; Breithardt G; Keating MT; Towbin JA; Beggs AH; Brink P; Wilde AA; Toivonen L; Zareba W; Robinson JL; Timothy KW; Corfield V; Wattanasirichaigoon D; Corbett C; Haverkamp W; Schulze-Bahr E; Lehmann MH; Schwartz K; Coumel P; Bloise R
    Circulation; 2001 Jan; 103(1):89-95. PubMed ID: 11136691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy of Beta-Blockers in Patients With Long QT Syndrome 1-3 According to Individuals' Gender, Age, and QTc Intervals: A Network Meta-analysis.
    Han L; Liu F; Li Q; Qing T; Zhai Z; Xia Z; Li J
    Front Pharmacol; 2020; 11():579525. PubMed ID: 33381033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.